Individual Stock News
1. Xizhi Technology-P (01879.HK) entered into a tutoring agreement for its A-share listing.
2. Tianshu Zhixin (09903.HK) reported cumulative chip shipments exceeding 80,000 units in the first 10 months.
3. Shenyan Intelligent (02723.HK) signed a strategic cooperation agreement with Baidu Smart Cloud to jointly promote integrated AI decision-making solutions.
4. Yingde Holdings (08535.HK) saw a change of controlling stake, with the acquiring company offering a full takeover bid at a discount of approximately 86.79%. Trading resumed on November 3.
5. Simcere Pharmaceutical (02096.HK) entered into an exclusive promotion service agreement with Lingke Pharmaceutical for the dermabrasion indication of zepxitinib.
6. Hengtai (00197.HK) announced its annual results: a net loss of approximately HK$232 million, a year-on-year increase of 13.3%. Trading resumed on November 3. 7. Hanteng Technology (02726.HK) issued a profit warning: Net profit for fiscal year 2026 is expected to be approximately RMB 108 million to RMB 158 million, representing a year-on-year increase of approximately 800% to 1217%.
8. Ingdan Innovation (00400.HK): For the three months ended September 30, 2026, the Group recorded revenue of approximately RMB 7.667 billion, an increase of approximately 130.1% compared to the same period in 2025.
9. CSPC Pharmaceutical Group (01093.HK): Positive top-line results were obtained from the Phase III clinical trial of pruluvilipin tablets in combination with dapagliflozin tablets and metformin hydrochloride extended-release tablets for the treatment of type 2 diabetes.
